Review
Published on 06 Dec 2023
Immunogenic chemotherapy: great potential for improving response rates
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1308681
- 2,629 views
- 10 citations
Type at least 3 characters
1,419 articles
Review
Published on 05 Dec 2023
Role of gonadally synthesized steroid hormones in the colorectal cancer microenvironment
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1323826
- 1,911 views
- 7 citations
Mini Review
Published on 04 Dec 2023
Circadian lifestyle determinants of immune checkpoint inhibitor efficacy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1284089
- 3,766 views
- 1 citation
Mini Review
Published on 01 Dec 2023
A narrative review of antibody–drug conjugates in EGFR-mutated non-small cell lung cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1252652
- 15,575 views
- 4 citations
Review
Published on 28 Nov 2023
The multiple roles of C-type lectin receptors in cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1301473
- 3,086 views
- 5 citations
Review
Published on 28 Nov 2023
Current tests for diagnosis of hepatitis B virus infection and immune responses of HBV-related HCC
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1185142
- 4,255 views
Case Report
Published on 28 Nov 2023
A case report and literature review on reactive cutaneous capillary endothelial proliferation induced by camrelizumab in a nasopharyngeal carcinoma patient
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1280208
- 1,577 views
- 2 citations
Original Research
Published on 28 Nov 2023
Immune checkpoint inhibitor-induced colitis with endoscopic evaluation in Chinese cancer patients: a single-centre retrospective study
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1285478
- 1,761 views
- 3 citations
Review
Published on 22 Nov 2023
Gut–lung axis: role of the gut microbiota in non-small cell lung cancer immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1257515
- 4,224 views
- 12 citations
Mini Review
Published on 22 Nov 2023
Cannabinoids and the endocannabinoid system in immunotherapy: helpful or harmful?
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1296906
- 6,025 views
- 10 citations
Original Research
Published on 22 Nov 2023
Immune changes in hilar tumor draining lymph nodes following node sparing neoadjuvant chemoradiotherapy of localized cN0 non-small cell lung cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1269166
- 2,590 views
- 2 citations
Original Research
Published on 20 Nov 2023
Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1259314
- 4,023 views
- 4 citations
Review
Published on 16 Nov 2023
Similarities and divergences in the metabolism of immune cells in cancer and helminthic infections
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1251355
- 2,794 views
- 2 citations
Review
Published on 15 Nov 2023
The power of phages: revolutionizing cancer treatment
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1290296
- 13,640 views
- 19 citations
Review
Published on 09 Nov 2023
Triple-negative breast cancer: from none to multiple therapeutic targets in two decades
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1244781
- 4,988 views
- 13 citations
Original Research
Published on 09 Nov 2023
Genomic alterations associated with pseudoprogression and hyperprogressive disease during anti-PD1 treatment for advanced non-small-cell lung cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1231094
- 2,351 views